| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.33B | 16.24B | 15.02B | 12.98B | 13.38B | 13.31B |
| Gross Profit | 10.12B | 10.23B | 9.64B | 8.05B | 8.81B | 8.00B |
| EBITDA | 2.79B | 2.91B | 2.52B | 1.46B | 2.82B | 2.48B |
| Net Income | 1.63B | 1.74B | 1.61B | 883.12M | 2.37B | 1.67B |
Balance Sheet | ||||||
| Total Assets | 32.10B | 34.97B | 33.56B | 30.61B | 28.38B | 25.38B |
| Cash, Cash Equivalents and Short-Term Investments | 19.02B | 21.84B | 21.03B | 18.42B | 16.09B | 12.05B |
| Total Debt | 15.00M | 16.00M | 1.46M | 3.96M | 114.92M | 0.00 |
| Total Liabilities | 14.37B | 15.69B | 14.59B | 12.82B | 11.10B | 9.38B |
| Stockholders Equity | 17.68B | 19.17B | 18.82B | 17.57B | 17.08B | 15.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.67B | 3.23B | 2.53B | 3.37B | 1.49B |
| Operating Cash Flow | 0.00 | 2.85B | 3.46B | 2.64B | 3.68B | 1.63B |
| Investing Cash Flow | 0.00 | -265.00M | 112.87M | -308.48M | 708.28M | 253.26M |
| Financing Cash Flow | 0.00 | -1.69B | -457.41M | -606.13M | -254.20M | -355.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥48.23B | 12.84 | 8.02% | 2.73% | 8.26% | 9.09% | |
73 Outperform | ¥48.14B | 9.37 | ― | 2.81% | 4.47% | 11.37% | |
72 Outperform | ¥51.17B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
68 Neutral | ¥32.90B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥6.77B | 27.15 | ― | ― | 11.32% | ― | |
59 Neutral | ¥8.56B | 54.21 | ― | 0.12% | 37.21% | 129.72% |